Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02272790
Title Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | CAN

Facility Status City State Zip Country Details
Research Site Gilbert Arizona 85234 United States Details
Research Site Tucson Arizona 85724 United States Details
Research Site La Jolla California 92093 United States Details
Research Site Los Angeles California 90024 United States Details
Research Site San Francisco California 94158 United States Details
Research Site Tampa Florida 33612 United States Details
Research Site West Palm Beach Florida 33401 United States Details
Research Site Augusta Georgia 30912 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site New York New York 10019 United States Details
Research Site New York New York 10065 United States Details
Research Site Cleveland Ohio 44195 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Abington Pennsylvania 19001 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Dallas Texas 75390 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Amsterdam 1066 CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field